1 / 45

Victor C. Urrutia, MD, FAHA Assistant Professor Director, The Johns Hopkins Hospital Stroke Center

Stroke Prevention, a New Approach. Victor C. Urrutia, MD, FAHA Assistant Professor Director, The Johns Hopkins Hospital Stroke Center Department of Neurology Johns Hopkins University School of Medicine vurruti1@jhmi.edu. Objectives. New TIA concept Review stroke risk factors

glyn
Télécharger la présentation

Victor C. Urrutia, MD, FAHA Assistant Professor Director, The Johns Hopkins Hospital Stroke Center

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Stroke Prevention, a New Approach Victor C. Urrutia, MD, FAHA Assistant Professor Director, The Johns Hopkins Hospital Stroke Center Department of Neurology Johns Hopkins University School of Medicine vurruti1@jhmi.edu

  2. Objectives • New TIA concept • Review stroke risk factors • Update on evidence based preventive interventions for intracranial stenosis • Present a new model for stroke prevention

  3. Disclosures • Atrial fibrillation advisory board (1/30/12). Janssen Pharmaceuticals • Johns Hopkins Hospital site PI for DIAS 4 (Lundbeck) and POINT (NINDS) • PI for SAIL ON, funded by Genentech • I will mention off label use of approved medications

  4. Introduction • WHO estimates that stroke is the 2nd leading cause of death in the world • 5.7 million affected each year • Stroke is the 4th leading cause of death in the US • 610, 000 1st time strokes • 65.5 billion in costs Roger VL, Go AS, Lloyd-Jones DM, et al. Circulation 2011 123:e18-e209

  5. Stroke or TIA? • “Transient ischemic attack (TIA): a transient episode of neurological dysfunction caused by a focal brain, spinal cord, or retinal ischemia, without acute infarction” Easton JD, Saver JL, Albers, GW, et al. Stroke 2009;40;2276-2293

  6. Transient Ischemic Attack • Class I recommendations • Patients with TIA should be evaluated as soon as possible (Level B) • Imaging within 24 hrs, MRI with DWI preferred (Level B) • Non invasive vascular imaging, head and neck (Level A) • EKG as soon as possible (Level B) Easton JD, Saver JL, Albers, GW, et al. Stroke 2009;40;2276-2293

  7. Transient Ischemic Attack • Class II recommendations • Echocardiogram (Class IIa, Level B) • Laboratory evaluation (Chemistry, CBC, PT, PTT, Lipid profile) • Hospitalization if within 72 hrs (Class IIa, Level C) • ABCD2>3 • ABCD2 0-2 uncertainty of speedy work up • ABCD2 0-2 and suspicion for brain ischemia Easton JD, Saver JL, Albers, GW, et al. Stroke 2009;40;2276-2293

  8. ABCD2 • Age ≥ 60 1 point if yes • BP ≥ 140/90 mmHg at initial evaluation? 1 point if yes • Clinical Features of the TIA: • Unilateral Weakness 2 points if yes • Speech Disturbance without Weakness 1 point if yes • Duration of Symptoms? • 10-59 minutes 1 point • ≥ 60 minutes 2 points • Diabetes Mellitus in Patient's History? 1 point if yes

  9. ABCD2 48hr Risk of Stroke • Score 0-1 = 0% • Score 2-3 = 1.3% • Score 4-5 = 4.1% • Score 6-7 = 8.1% Other predictors: • Acute stroke in MRI doubles the risk of short term stroke • A vessel occlusion in MRA increases it 4 times

  10. Risk factors Non-modifiable Modifiable Hypertension Smoking Diabetes Highblood cholesterol Atrial Fibrillation Large artery atherosclerosis Inactivity Obesity • Age • Gender • Race • Family History

  11. CHADS2 score http://www.healthsystem.virginia.edu/Internet/afibcenter/treatment.cfm

  12. Intracranial Stenosis

  13. SAMMPRIS • Enrolment stopped 4/11/11 • High grade (70-99%) stenosis of Intracranial ICA, vertebral, Basilar and M1 • Enrolled within 30 days of TIA or non-disabling stroke • Aggressive medical management: • Aspirin 325mg • Plavix 75mg for 90 days • Systolic <140 mmHg, <130mmHg if diabetic • LDL<70mg/dL • Lifestyle modification program

  14. SAMMPRIS • 451 patients out of 764 planned (59%) • 50 participating sites • Gateway-Wingspan system • 14% of patients in the angioplasty and stent died or had a stroke within 30 days vs 5.8% of those randomized to the medical arm Chimowitz MI, Lynn MJ, Derdeyn CP, et al. N Engl J Med 2011;365:993-1003

  15. How Are We Doing?

  16. Risk Factors • Approximately 34% of adults over age 20 have hypertension • 78% are aware of the diagnosis • 68% are using medications to control hypertension • 44 % are adequately controlled • Approximately 23% of men and 18% of women over age 18 are smokers • Approximately 8% of the adult population is diagnosed with Diabetes Mellitus NHANES 2005-2008

  17. Epidemiology of Risk Factors • 36.8% have pre-diabetes with abnormal fasting blood sugar • It is estimated that 33,600,000 adults older than 20 years of age have a total cholesterol > 240mg/dL • 33.7% of adults in the US are obese (BMI >30)

  18. Stroke in African Americans • Incidence of 1st ever stroke in AA is twice that of whites • AA younger than age 55 have 2 to 5X higher risk of death from stroke • In Maryland, black males have the highest rates of hospitalization for strokes, especially at younger ages • Approximately 44% of AA over age 20 have hypertension • In Maryland, rate of tobacco use is highest among black males

  19. North East Market Project

  20. Hypertension (NEMP 2008)

  21. Comparison of Risk Factors Market/Maryland (NEMP 2008)

  22. NEMP 2011

  23. Prevalence of Risk Factors * BRFSS – Behavior Risk Factor Surveillance Screen. 2009 - CDC

  24. Hypertension

  25. New Approach to Stroke Care • The multi disciplinary, guideline driven approach that has been successful in acute stroke care, has the potential for success in secondary and primary prevention

  26. N Engl J Med. 2010. 362;17:1555-1557

  27. AAN on Patient Centered Medical Home model “Yet there may still be a place for specialists who provide the majority of care (not primary care) to be the “home” for a patient, while the primary care physician still fills the rest of the role of the primary care provider.” http://www.aan.com/go/practice/models/pcmh

  28. Stroke Prevention and Recovery Center Stroke prevention education Provider Visit RN Visit Navigating the system/follow up call Database Screened for clinical trials Rehabilitation

  29. Integration of the Stroke System

  30. 48 hours post discharge Patient ready for discharge Day before clinic appointment Appointment • Nutritionist • Follow up results • Follow up visit • Tests • Follow up calls • Other specialties • PT/OT/SLT

  31. Accomplishments • Patient care coordination from hospital to clinic • Active BP management • Post clinic rounds • Nutritionist consult • Stroke Prevention Connection Newsletter • High risk patients from NEMP • Screened/follow up for Clinical trials (POINT, IRIS, P. Celnik) • Blood pressure, weight, BMI recorded in each visit http://www.hopkinsmedicine.org/news/e-newsletters/stroke_prevention/index.html

  32. Next Steps… • Truly integrate: • Prevention • Recovery • Research • One stop shop Tracking and altering the time course of spontaneous biological recovery after stroke PaBLO CELNIK (Johns Hopkins), ANDREAS LUFT (Zurich), JOEL Stein, ToMOKOKitago (Columbia) (Funding: McDonnell Foundation)

  33. How Does Recovery Work? Murphy TH, Corbett D. Nature Reviews/Neuroscience. 2009 10:861-872

  34. Recovery Duncan, et al. Measurement of Motor Recovery After Stroke. Stroke. 1992;23:1084-1089

  35. Interventions with a Possible Effect in Recovery • PT/OT/SLT • Transcranial Magnetic Stimulation • Transcranial Direct Current Stimulation • Peripheral stimulation or inhibition • Electric Stimulation • Robots • Constraint-Induced Therapy • Neurotransmitter modulation • SSRIs • Dopaminergic drugs, cholinesterase inhibitors

  36. Conclusions • The Stroke Prevention Clinic as a Specialty Medical Home is feasible. We have successfully established a system of care coordination and active risk factor management for stroke/TIA patients • Replication of the model at other hospitals will make analysis of clinical outcomes (recurrence rates) possible • This is a new platform for care, education and research

More Related